Casey Mogilevsky - Y Combinator Founder of Orikata Bio PBC
Home›Founders›Casey Mogilevsky
Casey Mogilevsky, Founder of Orikata Bio PBC

Casey Mogilevsky

CEO at Orikata Bio PBC

Founder and CEO of Orikata Bio PBC, building scientific AI software and biological models. Former UPenn MD/PhD student. At UC Berkeley, jointly advised by Matt Francis and Jennifer Doudna; three publications and a patent underlying Catena Bio (YC S21). At Cambridge, initiated a collaboration with David Baker's lab that later became part of Archon Bio. Goldwater Scholar, 2023 Regeneron Prize for Creative Innovation winner, 2024 Hertz finalist, and first author of an ICML 2026 paper.

Previously at

University of Pennsylvania Perelman School of Medicine
University of Pennsylvania Perelman School of Medicine
University of Cambridge Yusuf Hamied Department of Chemistry
University of Cambridge Yusuf Hamied Department of Chemistry
CatenaBio
CatenaBio
Catena Biosciences
Catena Biosciences
Igem At Berkeley
Igem At Berkeley
The Intermission Orchestra at UC Berkeley
The Intermission Orchestra at UC Berkeley
DeCal Program
DeCal Program
Phi Delta Epsilon, CA Iota
Phi Delta Epsilon, CA Iota
Innovative Genomics Institute
Innovative Genomics Institute
University of California, Berkeley, College of Chemistry
University of California, Berkeley, College of Chemistry
PEACE Tutoring
PEACE Tutoring
Alumnus of
Perelman School of Medicine, University of Pennsylvania
Perelman School of Medicine, University of Pennsylvania
University of Pennsylvania
University of Pennsylvania
University of Cambridge
University of Cambridge
University of California, Berkeley
University of California, Berkeley